New York State Common Retirement Fund Chimerix Inc Transaction History

New York State Common Retirement Fund

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$1.1 - $1.54 $54,340 - $76,076	-49,400 Reduced 98.68%	659 $1,000
Q4 2022 Jan 30, 2023	SELL	$1.67 - $2.35 $188 - $265	-113 Reduced 0.23%	50,059 $93,000
Q3 2022 Nov 08, 2022	BUY	$1.81 - $2.76 $539 - $822	298 Added 0.6%	50,172 $97,000
Q2 2022 Aug 04, 2022	SELL	$1.34 - $5.34 $226 - $902	-169 Reduced 0.34%	49,874 $104,000
Q1 2022 May 05, 2022	BUY	$4.58 - $6.8 $178 - $265	39 Added 0.08%	50,043 $229,000
Q4 2021 Feb 02, 2022	SELL	$5.23 - $7.18 $941 - $1,292	-180 Reduced 0.36%	50,004 $322,000
Q3 2021 Nov 02, 2021	SELL	$5.94 - $8.75 $76,002 - $111,956	-12,795 Reduced 20.32%	50,184 $311,000
Q2 2021 Aug 02, 2021	BUY	$7.54 - $9.79 $175,523 - $227,901	23,279 Added 58.64%	62,979 $504,000
Q1 2021 May 11, 2021	BUY	$4.76 - $11.25 $15,708 - $37,125	3,300 Added 9.07%	39,700 $383,000
Q2 2017 Aug 11, 2017	BUY	N/A	36,400	36,400 $198,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.